Skip to main content
Log in

Carbamazepine and its 10,11-epoxide in children and adults with epilepsy

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The plasma concentrations of carbamazepine and its 10,11-epoxide were measured in 37 children and 13 adults with epilepsy during maintenance therapy. The children formed relatively more of the epoxy metabolite than adults. The daily dose, expressed as mg/kg or mg/m2, showed a statistically significant correlation with blood level in children, but not in adults. The cerebrospinal fluid concentrations of carbamazepine and carbamazepine-10,11-epoxide in nine children were 33 and 41 per cent, respectively, of the concomitant plasma level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Faigle, J. W., Feldmann, K. F.: Pharmacokinetic data of carbamazepine and its major metabolites in man. In: Clinical pharmacology of antiepileptic drugs (ed. H. Schneider, D. Janz, C. Gardner-Thorpe, H. Meinardi, A. L. Sherwin), pp. 159–165. Berlin, Heidelberg, New York: Springer 1975

    Google Scholar 

  2. Morselli, P. L., Biandrate, P., Frigerio. A., Gerna, M., Tognoni, G.: Gas chromatographic determination of carbamazepine and carbamazepine 10,11-epoxide in human body fluids. In: Methods of analysis of antiepileptic drugs (ed. J. W. A. Meijer, H. Meinardi, C. Gardner-Thorpe, E. van der Kleijn), pp. 169–175. Amsterdam: Excerpta Medica 1973

    Google Scholar 

  3. Cereghino, J. J., Van Meter, J.C., Brock, J. T., Penry, J. K., Smith, L. D., White, B. G.: Preliminary observations of serum carbamazepine concentration in epileptic patients. Neurology (Minneap.)23, 357–366 (1973)

    Google Scholar 

  4. Cereghino, J. J., Brock, J. T., Van Meter, J. C., Penry, J. K., Smith, L. D., White, B. C.: Carbamazepine for epileptic patients. A controlled prospective evaluation. Neurology (Minneap.)24, 401–410 (1974)

    Google Scholar 

  5. Pynnönen, S., Frey, H., Sillanpää, M.: Concentrations of carbamazepine and its main metabolite 10,11-epoxy derivative in serum with a new GLC method. 21. Nordiska Neurologkongressen, Stockholm, June 11–14, 1975

  6. Clane, D. B.: Therapeutics in neurology, p. 15. Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications 1975

    Google Scholar 

  7. Eichelbaum, M., Ekbom, K., Bertilsson, L., Ringberger, V. A., Rane, A.: Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses. Eur. J. clin. Pharmacol.8, 337–341 (1975)

    Google Scholar 

  8. Troupin, A. S., Green, J. K., Halpern, L. M.: Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin). Acta neurol. scand. (Suppl.)50, 13–26 (1975)

    Google Scholar 

  9. Pynnönen, S., Sillanpää, M., Frey, H., Iisalo, E.: Serum concentration of carbamazepine: Comparison of Herrmann's spectrophotometric method and a new GLC method for the determination of carbamazepine. Epilepsia (Amst.)17, 67–72 (1976)

    Google Scholar 

  10. Frigerio, A., Baker, K. M., Blevedere, G.: Gas chromatographic degradation of several drugs and their metabolites. Anal. Chem.45, 1846–1851 (1973)

    Google Scholar 

  11. Garrettson, L. K., Dayton, P. G.: Disappearance of phenobarbital and diphenylhydantoin from serum of children. Clin. Pharmacol. Ther.11, 674–679 (1970)

    Google Scholar 

  12. Heinze, E., Kampffmeyer, H. G.: Biological half-life of phenobarbital in human babies. Klin. Wschr.49, 1146–1147 (1971)

    Google Scholar 

  13. Rane, A.: Urinary excretion of diphenylhydantoin metabolites in newborn infants. J. Pediat.85, 543–545 (1974)

    Google Scholar 

  14. Sherwin, A. L., Loynd, J. S., Bock, G. W., Sokolowski, C. D.: Effects of age, sex, obesity and pregnancy on plasma diphenylhydantoin levels. Epilepsia (Amst.)15, 507–521 (1974)

    Google Scholar 

  15. Alvares, A. P., Kapelner, S., Sassa, S., Kapps, A.: Drug metabolism in normal children, lead-poisoned children, and normal adults. Clin. Pharmacol. Ther.17, 179–183 (1975)

    Google Scholar 

  16. Christiansen, J., Dam, M.: Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy. Acta neurol. scand.49, (543–546 (1973)

    Google Scholar 

  17. Dam, M., Jensen, A., Christiansen, J.: Plasma level and effect of carbamazepine in grand mal and psychomotor epilepsy. Acta neurol. scand.60, (Suppl.) 33–38 (1975)

    Google Scholar 

  18. Schenkman, J. B., Robie, K. M., Jansoon, J.: In: Abstracts of Active intermediates: formation, toxicity and inactivation. IUPHAR Satellite Symposium, Turku, July 26–27, 1975

  19. Rane, A., Höjer, B., Wilson, J. T.: Kinetics of carbamazepine and its 10,11-epoxide metabolite in children. Clin. Pharmacol. Ther.19, 276–283 (1976)

    Google Scholar 

  20. Morselli, P. L.: Carbamazepine: Absorption, distribution and excretion. In: Complex partial seizures, Advances in Neurology (ed. J. K. Penry, D. D. Daly), pp. 279–293. New York: Raven Press 1975

    Google Scholar 

  21. Eichelbaum, M., Bertilsson, L., Lund, L., Palmer, L., Sjöquist, F.: Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy. Eur. J. clin. Pharmacol.9, 417–421 (1976)

    Google Scholar 

  22. Moeller, J.: Serumkoncentrations bestämningar av karbamazepin inom barnneurologin. In: Plasmakoncentrations bestämningar av antiepileptika; metodologiska och kliniska aspekter (ed. L. Lund), pp. 72–79, Lidingö: Tre punkter AB 1971

    Google Scholar 

  23. Scheiffarth, F., Weist, F., Zicha, L.: Zum Nachweis von 5-Carbamyl-5H-dibenzo(b,f)azepin im Liquor cerebrospinalis mittels Dünnschichtchromatographie. Z. klin. Chem.4, 68–70 (1966)

    Google Scholar 

  24. Weist, F., Zicha, L.: Dünnschichtchromatographische Untersuchungen über 5-Carbamyl-5H-dibenzo(b,f)azepin in Harn und Liquor bei neuen Indikationsgebieten. Arzneimittel-Forsch.17, 874–875 (1967)

    Google Scholar 

  25. Morselli, P., Frigerio, A.: Metabolism and pharmacokinetics of carbamazepine. Drug Metab. Rev.1, 97–113 (1975)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pynnönen, S., Sillanpää, M., Frey, H. et al. Carbamazepine and its 10,11-epoxide in children and adults with epilepsy. Eur J Clin Pharmacol 11, 129–133 (1977). https://doi.org/10.1007/BF00562904

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562904

Key words

Navigation